Breast Cancer

• CLINICAL_TRIALS trial_result · 2026-02-20
  Clinical Trial Update: The Effect of Neoadjuvant Chemotherapy on Physical Functions

  This clinical trial update reports on the effect of neoadjuvant chemotherapy on physical functioning in breast cancer patients. The study st…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents [Phase 1, Phase 2]

  Clinical trial update on ascending doses of ceralasertib in combination with chemotherapy or other anti-cancer agents in advanced solid mali…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer) [Phase 3]

  A Phase 3 clinical trial update comparing giredestrant plus palbociclib with letrozole plus palbociclib in ER-positive, HER2-negative locall…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer [NA]

  The clinical trial evaluating additional imaging methods for assessing axillary lymph node involvement in breast cancer has completed. Spons…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer. [Phase 2]

  This update notes a Phase 2 neoadjuvant trial of letrozole for postmenopausal women with HR-positive, HER2-negative, node-positive breast ca…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM) [NA]

  A precision oncology diagnostic study (PRISM) in primary and metastatic breast cancer is currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-02-20
  Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) [Phase 3]

  Phase 3 clinical trial update on evaluating giredestrant versus physician's choice of adjuvant endocrine therapy for estrogen receptor-posit…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer [Phase 2]

  Phase 2 clinical trial evaluating Efti in patients with hormone receptor-positive, HER2-negative breast cancer; not yet recruiting.

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers [NA]

  Clinical trial evaluating early multigene sequencing for theranostics in advanced cancers to guide therapy, across breast cancer, hepatocell…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: GammaPod Registry and Quality of Life Nomogram

  This clinical trial update describes the GammaPod Registry for breast cancer patients and a quality-of-life nomogram being studied. The tria…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer [NA]

  Sponsored by Fundacio Clinic Barcelona, the study evaluates diagnostic HER2DX-guided treatment for early-stage HER2-positive breast cancer. …

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: STOP-HER2: Stopping Trastuzumab in HER2+ MBC [Phase 2]

  Clinical trial update indicating the STOP-HER2 Phase 2 study investigating stopping trastuzumab in HER2-positive metastatic breast cancer.

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09) [Phase 3]

  This Phase 3 trial DESTINY-Breast09 is evaluating trastuzumab deruxtecan with or without pertuzumab versus a taxane-based regimen plus trast…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Auricular Acupressure for Perioperative Anxiety and Pain in Therapeutic Breast Surgery (ROSA) [NA]

  Clinical trial update on auricular acupressure to reduce perioperative anxiety and pain in women undergoing therapeutic breast surgery; recr…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer [NA]

  A clinical trial is evaluating FDG-PET/CT versus conventional CT for monitoring metastatic breast cancer. The study is currently recruiting.

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

  Clinical trial evaluating circulating tumor DNA as an early biomarker to assess treatment response across multiple solid tumors; currently r…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Onco-primary Care Networking to Support TEAM-based Care [NA]

  Clinical trial update noting that the Duke University study on oncology-primary care networking to support TEAM-based care is currently ACTI…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Oncology Episode Payment Model in Hawaii [NA]

  An update on an oncology episode payment model trial in Hawaii sponsored by the University of Pennsylvania. The study covers breast cancer, …

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Sexual Functıon in Young Women After Breast Cancer Surgery

  This entry reports a clinical trial recruiting young adult women after breast cancer surgery to evaluate sexual function outcomes.

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: The Florida ASCENT Study [NA]

  The Florida ASCENT Study, sponsored by the University of Florida, is currently recruiting and investigates cancer outcomes in the context of…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Three Fraction Radiation to Induce Immuno-Oncologic Response [NA]

  Clinical trial update on using three fractions of radiation to induce an immuno-oncologic response in locally advanced breast cancer; the st…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors [NA]

  This entry reports an active, non-recruiting clinical trial evaluating abbreviated MBCT to treat depression in older African American/Black …

• CLINICAL_TRIALS other · 2026-02-20
  Clinical Trial Update: Step Count and Treatment Response in Neoadjuvant Breast Cancer

  Ongoing clinical trial recruitment for a neoadjuvant breast cancer study. The study examines whether step counts and wearable technology rel…

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. [NA]

  This clinical trial is investigating expression of DNA double-strand break repair factors (POLQ, Shieldin complex, and 53BP1) as biomarkers …

• CLINICAL_TRIALS research · 2026-02-19
  Clinical Trial Update: Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]

  AZD5305 is being evaluated as a monotherapy and in combination with anti-cancer agents in a Phase 1/2 trial for multiple advanced solid mali…